H.C. Wainwright raised the firm’s price target on Ovid Therapeutics (OVID) to $2 from $1.50 and keeps a Buy rating on the shares. OV329’s initial clinical data show robust safety and position the ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

On Tuesday, H.C. Wainwright analyst Raghuram Selvaraju adjusted the price target for Ovid Therapeutics Inc (NASDAQ: OVID) to $1.50, down from the previous $2.00, while maintaining a Buy rating on the ...

Minor injuries were involved and 15 to 20 people were displaced after a massive fire broke out in Ovid Tuesday evening and into Wednesday morning, the Seneca County Sheriff's Office announced ...

NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to improving the lives of people affected by rare epilepsies and brain ...

On Monday, H.C. Wainwright adjusted its outlook on Ovid Therapeutics Inc (NASDAQ: OVID), reducing the 12-month price target to $2.00 from the previous $3.00. The stock, currently trading at $0.43 and ...

OVID, N.Y. — More than two months after a massive fire ravaged Main Street in the village of Ovid, the community is rallying to support recovery efforts. The fire, which destroyed the town's only ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.